Matt Frevel

Director de Operaciones en Migco Pharmaceuticals Ltd. .

Consumer Services

Health Technology

Perfil

Matt Frevel is currently the Chief Operating Officer at Migco Pharmaceuticals Ltd.
and the Chief Scientific Officer at Enzo Nutraceuticals Ltd.
He holds a doctorate degree from the University of Otago and an undergraduate degree from the University of Bonn.

Cargos activos de Matt Frevel

Empresas	Cargo	Inicio
Migco Pharmaceuticals Ltd. Migco Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Migco Pharmaceuticals Ltd. develops new drug therapeutic products. The firm is focused on developing new drug therapies for the prevention and treatment of migraine headaches. It has clinical safety data for its lead compound MGX-008. The company was founded by Larry Ellsworth Stenswick in 2004 and is headquartered in Rangiora, New Zealand.	Director de Operaciones	-
Enzo Nutraceuticals Ltd.	Director Técnico/Científico/I+D	-

Todos los cargos activos de Matt Frevel

Formación de Matt Frevel.

University of Bonn	Undergraduate Degree
University of Otago	Doctorate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Matt Frevel.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Migco Pharmaceuticals Ltd. Migco Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Migco Pharmaceuticals Ltd. develops new drug therapeutic products. The firm is focused on developing new drug therapies for the prevention and treatment of migraine headaches. It has clinical safety data for its lead compound MGX-008. The company was founded by Larry Ellsworth Stenswick in 2004 and is headquartered in Rangiora, New Zealand.	Health Technology
Enzo Nutraceuticals Ltd.